When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

PD-1 inhibitor Keytruda (pembrolizumab) has been cleared in combination with trastuzumab ... the EU diagnosed with HER2-positive advanced gastric cancer face an aggressive disease associated ...

FDA approved Keytruda with Herceptin and chemotherapy for HER2-positive gastric/GEJ adenocarcinoma with ... The findings showed that patients receiving pembrolizumab had a longer period before their ...

Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.

Locally Advanced or Metastatic Gastric Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or ...